Clinical trial
The Predictive Effect of Soluble Epoxide Hydrolase (SEH) on Depression Treatment, Cognition and Suicide Improvement
NCT05575713 is registered in ClinicalTrials.gov with Nanfang Hospital, Southern Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Predictive Effect of Soluble Epoxide Hydrolase (SEH) on Depression Treatment, Cognition and Suicide Improvement
- Lead sponsor
- Nanfang Hospital, Southern Medical University
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 1, 2019
- Completion date
- October 31, 2024
- Enrollment
- 330 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.